ストックスクリーナーアプリを入手
7.00
3.58%
-0.26
前日終値:
$7.26
開ける：
$7.24
24時間の取引高:
2.78M
Relative Volume:
0.69
時価総額：
$1.17B
収益：
$847.25M
当期純損益:
$-284.86M
株価収益率:
-3.0568
EPS:
-2.29
ネットキャッシュフロー:
$-112.35M
1週間 パフォーマンス:
-7.89%
1か月 パフォーマンス:
-0.85%
6か月 パフォーマンス:
-47.37%
1年 パフォーマンス:
+46.44%
1日の値動き範囲:
$6.93
$7.289
1週間の範囲:
$6.93
$7.81
52週間の値動き範囲:
$3.81
$23.86
Novavax Inc Stock (NVAX) Company Profile
NVAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.00 | 1.17B | 847.25M | -284.86M | -112.35M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-28 | 開始されました | BTIG Research | Buy |
| 2024-07-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-05-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-05-10 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-08-09 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | 繰り返されました | B. Riley Securities | Buy |
| 2022-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2022-12-02 | 開始されました | Jefferies | Hold |
| 2022-09-22 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2022-02-22 | 再開されました | Jefferies | Buy |
| 2022-01-21 | 開始されました | Cowen | Outperform |
| 2021-05-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-14 | 開始されました | Jefferies | Buy |
| 2020-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-05 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-08-05 | ダウングレード | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-08 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | 繰り返されました | B. Riley FBR | Buy |
| 2020-06-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-05-28 | 繰り返されました | B. Riley FBR | Buy |
| 2020-05-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-08-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-28 | ダウングレード | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-12-11 | 開始されました | Oppenheimer | Outperform |
| 2018-11-26 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | アップグレード | JP Morgan | Underweight → Overweight |
| 2018-03-29 | アップグレード | Seaport Global Securities | Neutral → Buy |
すべてを表示
Novavax Inc (NVAX) 最新ニュース
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Novavax (NVAX) Dipped More Than Broader Market Today - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?Moderna (NASDAQ:MRNA) - Benzinga
Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com Australia
Where are the Opportunities in (NVAX) - Stock Traders Daily
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
The industry heavyweight behind Novavax’s push to bounce back - PharmaVoice
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
Ebola Vaccine Market Generated Opportunities, Future Scope - openPR
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying - The Motley Fool
Canada cancels Novavax Covid vaccine purchase - New Vision
Canada cancels purchase of Covid-19 vaccine from Novavax - БГНЕС
Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates - Simply Wall St
Head to Head Analysis: TScan Therapeutics (NASDAQ:TCRX) versus Novavax (NASDAQ:NVAX) - Defense World
Novavax Announces Board Changes and Strategic Shift - TipRanks
Novavax appoints new chair as James Young retires By Investing.com - Investing.com Australia
Need To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance
Federal government cancels deal with US company to make COVID-19 vaccine in Montreal - Montreal Gazette
Novavax faces contract termination with Canadian government By Investing.com - Investing.com South Africa
Novavax falls as Canada terminates COVID-19 vaccine purchase deal - TradingView
Canada Cancels Novavax Covid Vaccine Purchase - Barron's
Novavax Faces Contract Termination with Canadian Government - TipRanks
Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows - Marketscreener.com
Novavax: retirement of the Chairman of the Board of Directors -March 11, 2025 at 09:55 am EDT - Marketscreener.com
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership - MSN
Novavax faces contract termination with Canadian government - Investing.com India
Novavax Chair James Young Retires; Margaret McGlynn Named Successor -March 11, 2025 at 09:02 am EDT - Marketscreener.com
Novavax appoints new chair as James Young retires - Investing.com India
Novavax Reshapes Leadership: Vaccine Industry Veteran Takes Board Chair Amid Strategic Shift - StockTitan
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax Applies Lessons Learned From Turbulent COVID-19 Experience - BioSpace
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Novavax, Inc. to Host Earnings Call - ACCESS Newswire
Novavax, Inc. (NASDAQ:NVAX) Shares Bought by Oppenheimer & Co. Inc. - Defense World
Novavax (NasdaqGS:NVAX) Shares Rise 11% Following Q4 2024 Earnings Improvement - Yahoo Finance
Novavax (NVAX) Predicts Profitability by 2027 Despite Recent Stock Drop - Markets Insider
B. Riley Issues Pessimistic Estimate for Novavax Earnings - Defense World
Novavax, Inc. (NASDAQ:NVAX) Shares Bought by Rhumbline Advisers - Defense World
(NVAX) Investment Report - news.stocktradersdaily.com
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - MSN
Novavax Inc (NVAX) 財務データ
収益
当期純利益
現金流量
EPS
Novavax Inc (NVAX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 07 '25 |
Option Exercise |
0.00 |
12,223 |
0 |
75,155 |
| Trizzino John | President and COO |
Mar 01 '25 |
Option Exercise |
0.00 |
48,000 |
0 |
76,310 |
| Casey Mark J | EVP, Chief Legal Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
33,187 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 01 '25 |
Option Exercise |
0.00 |
58,667 |
0 |
91,269 |
| Jacobs John C | President and CEO |
Mar 01 '25 |
Option Exercise |
0.00 |
83,334 |
0 |
175,183 |
| O'Hara Elaine | EVP, Chief Strategy Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
59,600 |
0 |
73,825 |
| Jacobs John C | President and CEO |
Jan 23 '25 |
Option Exercise |
0.00 |
83,196 |
0 |
130,722 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Dec 31 '24 |
Option Exercise |
0.00 |
35,000 |
0 |
49,508 |
| Rodgers Richard J | Director |
Oct 29 '24 |
Option Exercise |
0.00 |
3,800 |
0 |
14,270 |
| King Rachel K. | Director |
Dec 13 '24 |
Sale |
9.02 |
4,150 |
37,435 |
14,770 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):